Not eight months after Covid-19 vaccines made their debut, hailed as a “miracle of science” and the “end of the pandemic,” it now looks like there will no end to the vaccines.
Remember when it was so important for people to get their second dose? Well now, just months later, it’s a third dose. Soon it will be so important for people to roll up their sleeve for their booster shot – for the sake of everyone’s health, of course. But no one really believes it ends with a single booster, do they?
Vaccine-maker Moderna sure doesn’t; it announced this week that it has inked a contract with the government of Canada to supply 20 million doses of its experimental mRNA shot (with an extra 15 million doses thrown in if required) for each of 2022, 2023 and 2024. Not a bad deal for your first product ever to market — and a drug that’s still in clinical trials to boot.
Especially since Moderna has some problems with the safety of its novel platform mRNA vaccine. Former New York Times writer Alex Berenson reported recently that over just three months after the launch of its novel Covid vaccine, Moderna received 300,000 reports of vaccination side effects, according to an internal report from a company that helps Moderna manage the reports. This is much higher than the numbers reported on the official government vaccine adverse event reporting system that Moderna is required by law to report side effects to.
This week, it was reported that U.S. health officials are reviewing reports that Moderna’s vaccine may be linked to a higher risk of myocarditis – an inflammatory heart condition — in younger adults than previously thought.
Heart inflammation was detected in one data set at a rate of 12.6 per million in 12-to 39-year-olds who got Moderna shots. That’s 12 times higher than the “one in a million” people are told to expect for vaccine adverse events – and it’s just one unexpected life-threatening side effects that has emerged in recent months.
Never mind. There’s 105 million doses of Moderna vaccine coming for an entire population of 37 million men, women, and children, including babies. Roll up your sleeves, Canada!
But that’s just the start. Remember way back four weeks ago when the mainstream media echo chamber was asking (as if they didn’t know the answer), if we would need an extra vaccine dose? That’s when the FDA pushed Pfizer back on its booster like a coquettish teenager and said its third dose wasn’t necessary — just yet anyway. Then it rushed headlong into the affair just weeks later. Just weeks after that, the FDA had an Emergency Use Authorization contract in hand and Pfizer had the go-ahead to start doling out its boosters in the United States in September.
Everyone knew the FDA’s pushback was a false show of refusal, didn’t they? Someone in the government of Canada sure did. Way back in April, even before Anthony Fauci began warming Americans up to the idea of booster shots, long before the whole Pfizer-FDA tango, Canadian Prime Minister Justin Trudeau announced at a press conference that his government had secured 35 million Pfizer booster shots for 2022 and another 33 million doses for 2023.
The deal had options to add 30 million doses in both ‘22 and ‘23, and an option for 60 million doses in ‘24, he told reporters.
That’s 188 million Pfizer shots. Added to Moderna’s supply that’s 293 million vaccine doses — enough injections to shoot every Canadian nearly eight times over in just three years. Do you think they might have a few booster shots a year in mind? Or are the extras for Canadian cats, perhaps?